You don’t need a doctoral degree in finance to calculate your portfolio’s investment returns. A few principles are enough to turn even the most math-phobic people into shrewd investors. While basic ...

Deciding where to invest your capital is one of the most critical decisions a business owner or a financial manager can make. It’s a process of weighing potential returns against the risks of a ...

There’s never a guarantee when it comes to betting, but there are ways to maximise potential returns to help you with your own betting strategy – and you can do all that and more with our betting ROI ...

Investment word of the day: Tracking your investments is essential for understanding how your money performs over time. Skipping this practice will make it difficult to know if you're on the right ...

Doug Wintemute is a staff writer for Forbes Advisor. After completing his master’s in English at York University, he began his writing career in the higher education space. Over the past decade, Doug ...

Here’s how investing in UK and US shares could turn £500 a month in a Stocks and Shares ISA and Cash ISA into a large second income. When investing, your capital is at risk. The value of your ...

PEKIN, Ill., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, announced ...

BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that Immunome ...

An events company in charge of the return of Blackheath's annual fireworks display has applied to host 29,999 people at the event. The last time the display took place was before the pandemic. It has ...

AUSTIN, Texas, Sept. 2, 2025 /PRNewswire/ -- Ideal Power Inc. (Nasdaq: IPWR) ("Ideal Power," the "Company," "we," "us" or "our"), developer and innovative provider of the highly efficient and broadly ...

MALVERN, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced ...